Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Abcellera Biologics Inc; Transgenic mice

Active

Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract involves Abcellera Biologics Inc and pertains to the procurement of transgenic mice for the Centers for Disease Control and Prevention (CDC). Announced as a forecast on March 11, 2026, the contract details remain preliminary with no specific solicitation number, NAICS code, or set-aside status provided. The contract aims to support CDC's research and development efforts, likely focusing on advanced biological studies requiring genetically modified animal models. Key points include the involvement of the CDC as the contracting agency, with contact persons listed for program coordination and contracting duties, though the contracting officer has yet to be named. The place of performance and other logistical specifics have not been disclosed. Interested parties seeking further information or engagement are directed to reach out via the provided email contacts or visit the official industry opportunity forecast website.

General Info

Abcellera Biologics to supply transgenic mice for CDC research; contract details preliminary.

Agency

Centers for Disease Control and Prevention → Centers For Disease Control And Prevention

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing View NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedMay 25

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyCenters for Disease Control and Prevention → Centers For Disease Control And Prevention

Contacts2 people available

OfficeN/A

Organization / Agency

Centers for Disease Control and Prevention → Centers For Disease Control And Prevention

Office AddressN/A

Contacts

Charmaine Mckenzie

contact@example.gov

To Be Determined To Be DeterminedContracting Officer

contact@example.gov

Full Description

Show more

Abcellera Biologics Inc; Transgenic mice

Similar Contracts

iNDI FA13.1J Cell Lines Expansion and Distribution for the iPSC Neurodegenerative Disease Initiative (iNDI) ProjectThe Department of Health and Human Services, through the National Institutes of Health's National Institute on Aging, intends to award a sole source contract to The Jackson Laboratory for the expansion, quality control, biobanking, and distribution of isogenic Alzheimer’s disease and related dementias induced pluripotent stem cell lines as part of the iPSC Neurodegenerative Disease Initiative (iNDI) Project. This contract will focus on providing up to 936 specific iPSC lines, including 486 FA13.1J female SNV lines and 450 lines across 25 high-priority SNV trios, adhering to iNDI protocols for quality and expansion. The Jackson Laboratory is uniquely qualified for this contract as it currently houses the existing distribution infrastructure and has demonstrated successful past performance in supporting NIH’s iNDI requirements. The contract is planned to be a firm-fixed-price agreement with a performance period starting September 1, 2026, for a base year and up to three option years, ending August 31, 2030. The primary place of performance will be the contractor’s facility in Bar Harbor, Maine. While this notice signals the intent for a sole source award, other capable sources may submit capability statements demonstrating their ability to meet the outlined requirements, including supply of the specific cell lines, adherence to quality protocols, product and web content creation, and public distribution via an established platform. Responses must be submitted electronically by June 23, 2026, and the Government reserves the right to consider all responses but is under no obligation to initiate a competitive procurement.

National Institutes Of Health Olao

POSTED

about 18 hours ago

DEADLINE

VARICELLA VIRUS VACThe contract pertains to the procurement of a Varicella Virus vaccine, identified by NSN/Part Number 6505-01-413-1331, with a purchase request quantity of one unit. This solicitation, designated SPE2DP-26-T-3771, was issued by the Defense Logistics Agency under the Department of Defense. The solicitation was posted on June 10, 2026, with a response deadline set for June 16, 2026. The contract is classified as a federal solicitation without any specified set-aside type or NAICS code, indicating it is open without particular restrictions. The place of performance and detailed office address information are not provided, nor are specific points of contact listed. The solicitation and related documents are accessible through the Defense Logistics Agency's contracting portal, reflecting the agency's role in coordinating this acquisition.

Defense Logistics Agency

POSTED

DEADLINE

Proficiency Test Panel Manufacturing and AssemblyThis contract involves the preparation, aliquoting, labeling, and quality control of diagnostic test panels, all carried out under controlled and sterile conditions to maintain the consistency and integrity of biological materials. The services are essential for ensuring reliable and standardized diagnostic panels used for proficiency testing. The work will take place in Glasgow, with the subcontract issued by the CDC Office of Acquisition Services under the Department of Health and Human Services. The contract falls within the NAICS code 325414, which pertains to biological product manufacturing. The solicitation was posted on June 10, 2026, with a response deadline of June 22, 2026, by 3:00 PM. Although the solicitation number and type of set-aside are not specified, this subcontract opportunity emphasizes high-quality manufacturing practices in a sterile environment, reflecting stringent quality assurance standards. The contract's purpose is aligned with public health priorities, supporting diagnostic accuracy and consistency in testing protocols.

CDC Office Of Acquisition Services

POSTED

DEADLINE

Supply of USDA-Licensed Babesia caballi Antibody Test Kits (cELISA)The contract involves the supply of USDA-licensed competitive ELISA (cELISA) test kits specifically designed for detecting Babesia caballi antibodies in equine blood samples. These test kits are essential for identifying the presence of this particular parasite, which affects horses, and play a crucial role in equine health monitoring and disease control. The Department of Agriculture and Consumer Services in Florida is the contracting agency responsible for this procurement. The solicitation was posted on June 9, 2026, with a submission deadline of June 30, 2026. It is a subcontract opportunity under the NAICS code 325414, which pertains to biological product manufacturing. Although specific location details for performance and the point of contact are not provided, interested vendors can access more information and submit responses through the Florida state’s vendor marketplace. The contract underscores the importance of USDA licensing, ensuring that the test kits meet regulatory standards for quality and reliability in diagnostic applications.

Department of Agriculture and Consumer Services

POSTED

DEADLINE

Supply of USDA-Licensed Babesia equi Antibody Test Kits (cELISA)The contract involves the supply of USDA-licensed competitive ELISA (cELISA) test kits designed specifically for detecting antibodies against Babesia equi, now known as Theileria equi, in horses. These test kits are critical for monitoring and diagnosing equine infections, ensuring animal health and compliance with biosecurity standards. The procurement is managed by the Department of Agriculture and Consumer Services in Florida and falls under the NAICS code 325414, which covers biological product manufacturing. The solicitation for this subcontract was posted on June 9, 2026, with a response deadline set for June 30, 2026. Although specific details such as the place of performance and point of contact were not provided, interested vendors can access further information through the designated vendor marketplace link. This contract represents a targeted effort to source high-quality, licensed diagnostic tools essential for equine disease control and agricultural health monitoring in the state.

Department of Agriculture and Consumer Services

POSTED

DEADLINE